Sexuality and intimacy after gynecological cancer

Maturitas

Volumn 66, Issue 1, 2010, Pages 23-26

  Ratner, Elena S ^a   Foran, Kelly A ^a   Schwartz, Peter E ^a   Minkin, Mary Jane ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial cancer; Gynecologic cancer; Hormone replacement therapy; Intimacy; Ovarian cancer; Psychologic modifications; Sexuality

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; FLUOXETINE; GABAPENTIN; GONADORELIN AGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RALOXIFENE; TIBOLONE; VENLAFAXINE;

ANGER; ANXIETY; AROUSAL; BEHAVIOR THERAPY; CANCER PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE THERAPY; DEPRESSION; DIETARY INTAKE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ENDOMETRIUM CANCER; EXERCISE; FATIGUE; GYNECOLOGIC CANCER; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INTIMACY; LIBIDO DISORDER; MORBIDITY; ORGASM; OSTEOPOROSIS; OVARY CANCER; PAIN; PATIENT SATISFACTION; POSTMENOPAUSE OSTEOPOROSIS; PROSTATE CANCER; PSYCHOEDUCATION; PSYCHOLOGIST; PSYCHOTHERAPY; REVIEW; SEXUAL FUNCTION; SEXUALITY; SLEEP DISORDER; STRESS; SURVIVAL TIME; UTERINE CERVIX CANCER; VAGINA CANCER; VASOMOTOR DISORDER; VULVA CANCER; WELLBEING; COMPLICATION; FEMALE; GENITAL NEOPLASMS, FEMALE; NEOPLASMS; PSYCHOLOGY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

FEMALE; GENITAL NEOPLASMS, FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; NEOPLASMS; PSYCHOTHERAPY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUAL PARTNERS; SEXUALITY;

EID: 77950817922     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.01.015     Document Type: Review

References (22)

1. Juraskova I., Butow P., Robertson R., Sharpe L., McLeod C., and Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncology 12 (2003) 267-279
2. Bodurka D.C., and Sun C.C. Sexual function after Gynecologic Cancer, Obstetrics and Gynecology Clinics of North America, vol. 33(4). Sexual dysfunction 12 (2006) p. 621-30
3. Park E.R., Norris R.L., and Bober S.L. Sexual health communication during cancer care: barriers and recommendations. Cancer J 15 (2009) 74-77
4. Stead M., Brown J.M., Fallowfield L., and Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 88 (2003) 666-671
5. Stead M., Fallowfield L., Brown J., and Selby P. Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study. BMJ 323 October (7317) (2001) 836-837
6. Brotto L.A., Heiman J.R., Goff B., et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav 37 2 (2008) 317-329
7. Michael R.T., Gagnon J.H., Laumann E.O., and Kolata K. Sex in America: a definitive survey (1995), Little, Brown, Boston
8. Hollingsworth M., and Berman J. The role of androgens in female sexual dysfunction. Sexual Reprod Menopause 4 1 (2006) 27-332
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th., text rev.) (2000), Author, Washington, DC
10. Hartmann U., Philippsohn S., Heiser K., et al. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause 11 6 (2004) 727-740
11. Hawkins Y., Ussher J., Gilbert E., Perz J., Sandoval M., and Sundquist K. Changes in sexuality and intimacy after the diagnosis and treatment of cancer: the experience of partners in a sexual relationship with a person with cancer. Cancer Nurs 32 July-August (4) (2009) 271-280
12. Allison M.A., and Manson J.E. Hormone replacement therapy. Encyclopedia of epidemiology (2007), Sage Publications, Thousand Oaks, CA p. 503-10
13. American Cancer Society-Cancer Facts & Figures; 2008. At: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf.
14. Ploch E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol Oncol 26 (1987) 169-177
15. Michaelson-Cohen R., and Beller U. Managing menopausal symptoms after gynecologic cancer. Curr Opin Oncol 21 (2009) 407-411
16. Creasman W. Hormone replacement therapy after cancers. Curr Opin Oncol 17 (2005) 493-499
17. Creasman W.T., Henderson D., Hinshaw W., et al. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 67 (1986) 326-330
18. Lee K.B., Lee J.M., Lee J.K., and Cho Ch. Endometrial cancer patients and Tibolone: a matched case-control study. Maturitas 55 (2006) 264-269
19. Loprinzi C.L., Sloan J.A., Perez E.A., et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20 (2002) 1578-1583
20. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 356 (2000) 2059-2063
21. www.oncolink.org
22. www.cancerbacup.org.uk